ATE133663T1 - Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol - Google Patents

Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol

Info

Publication number
ATE133663T1
ATE133663T1 AT91103425T AT91103425T ATE133663T1 AT E133663 T1 ATE133663 T1 AT E133663T1 AT 91103425 T AT91103425 T AT 91103425T AT 91103425 T AT91103425 T AT 91103425T AT E133663 T1 ATE133663 T1 AT E133663T1
Authority
AT
Austria
Prior art keywords
arylcarbonyl
aminoalkyl
compositions containing
antiglancoma
indole
Prior art date
Application number
AT91103425T
Other languages
English (en)
Inventor
Susan Jean Ward
Malcolm Rice Bell
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Application granted granted Critical
Publication of ATE133663T1 publication Critical patent/ATE133663T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
AT91103425T 1990-03-08 1991-03-06 Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol ATE133663T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49020190A 1990-03-08 1990-03-08

Publications (1)

Publication Number Publication Date
ATE133663T1 true ATE133663T1 (de) 1996-02-15

Family

ID=23947024

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91103425T ATE133663T1 (de) 1990-03-08 1991-03-06 Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol

Country Status (21)

Country Link
EP (1) EP0445781B1 (de)
JP (1) JP3157179B2 (de)
KR (1) KR0183396B1 (de)
AT (1) ATE133663T1 (de)
AU (1) AU643757B2 (de)
CA (1) CA2036307C (de)
DE (1) DE69116705T2 (de)
DK (1) DK0445781T3 (de)
ES (1) ES2082872T3 (de)
FI (1) FI95369C (de)
GR (1) GR3019058T3 (de)
HU (1) HU215125B (de)
IE (1) IE72953B1 (de)
IL (1) IL97426A (de)
MX (1) MX174433B (de)
MY (1) MY106109A (de)
NO (1) NO179612C (de)
NZ (1) NZ237309A (de)
PH (1) PH27022A (de)
PT (1) PT96938B (de)
RU (1) RU2073670C1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
FR2713224B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
ES2099007B1 (es) * 1993-07-16 1997-12-01 Pfizer Res & Dev Derivados de indol.
FR2714057B1 (fr) * 1993-12-17 1996-03-08 Sanofi Elf Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
BR9910149A (pt) * 1998-05-01 2001-10-02 Lilly Co Eli éster inibidor de spla2
EP0985414B1 (de) * 1998-05-26 2003-08-27 Pfizer Products Inc. Medikament zur Behandlung von Glaukoma und ischämischer Retinopathie
WO2001040183A1 (en) * 1999-12-03 2001-06-07 Alcon Universal Ltd. 1-aminoalkyl-1h-indoles for treating glaucoma
AU771130B2 (en) * 2000-01-18 2004-03-11 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
JP2004502642A (ja) * 2000-02-11 2004-01-29 ブリストル−マイヤーズ　スクイブ　カンパニー カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用
SE0203070D0 (en) * 2002-10-16 2002-10-16 Astrazeneca Ab Novel compounds
TW200508197A (en) 2003-03-31 2005-03-01 Ucb Sa Indolone-acetamide derivatives, processes for preparing them and their uses
FR2893615B1 (fr) * 2005-11-18 2008-03-07 Sanofi Aventis Sa Derives de 3-acylindole, leur preparation et leur application en therapeutique
KR101723125B1 (ko) 2015-07-29 2017-04-04 이은솔 개선된 구조의 위생 젓가락
JP6025234B1 (ja) * 2016-03-10 2016-11-16 株式会社サンライフ 箸における箸置き形成方法及び箸置き機能を有する箸
CN107628981B (zh) * 2017-10-31 2019-07-30 威海市妇女儿童医院 一种肉桂酰基吲哚啉化合物及其制备青光眼药物的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1436771A (en) * 1973-02-16 1976-05-26 Labaz Indole derivatives and process for preparing the same
US4581354A (en) * 1984-08-06 1986-04-08 Sterling Drug Inc. 3-arylcarbonyl- and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles, compositions and use
US4634776A (en) * 1984-08-06 1987-01-06 Sterling Drug, Inc. 3-arylcarbonyl-and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles
US4634698A (en) * 1984-09-24 1987-01-06 Schering Corporation Antiglaucoma agents
DE3821148A1 (de) * 1988-06-23 1989-12-28 Erwin Von Dr Angerer Aminoalkylindole, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
FI95369B (fi) 1995-10-13
AU643757B2 (en) 1993-11-25
EP0445781A1 (de) 1991-09-11
NO179612B (no) 1996-08-05
CA2036307C (en) 2002-07-09
IE910700A1 (en) 1991-09-11
IL97426A0 (en) 1992-06-21
MX24839A (es) 1993-10-01
FI95369C (fi) 1996-01-25
FI911131A0 (fi) 1991-03-06
NO910868D0 (no) 1991-03-05
HU215125B (hu) 1998-09-28
GR3019058T3 (en) 1996-05-31
RU2073670C1 (ru) 1997-02-20
JP3157179B2 (ja) 2001-04-16
DE69116705T2 (de) 1996-09-26
EP0445781B1 (de) 1996-01-31
NO179612C (no) 1996-11-13
NO910868L (no) 1991-09-09
ES2082872T3 (es) 1996-04-01
KR0183396B1 (ko) 1999-05-01
KR910016745A (ko) 1991-11-05
PT96938A (pt) 1991-10-31
PT96938B (pt) 1998-07-31
NZ237309A (en) 1993-02-25
MY106109A (en) 1995-03-31
PH27022A (en) 1993-02-01
CA2036307A1 (en) 1991-09-09
FI911131A (fi) 1991-09-09
HUT56492A (en) 1991-09-30
DE69116705D1 (de) 1996-03-14
JPH04235164A (ja) 1992-08-24
DK0445781T3 (da) 1996-02-19
MX174433B (es) 1994-05-16
AU7266991A (en) 1991-09-12
IE72953B1 (en) 1997-05-07
IL97426A (en) 1996-03-31

Similar Documents

Publication Publication Date Title
DE69116705D1 (de) Antiglancoma-Zusammensetzungen enthaltend 3-Arylcarbonyl-1-aminoalkyl-1H-indol
DK0472327T3 (da) Præparat på form af øjendråber
DK0411733T3 (da) 11-beta-aryl-gona-4,9-dien-3-oner
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
ATE109465T1 (de) 4-aryl-4-piperidine (oder -pyrrolidin- oder - hexahydroazepin-) carbinole und heterocyclische analoga davon.
ES2044100T4 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
FR2483234B2 (de)
DE3886314D1 (de) Substituierte Thieno(2,3-b) thiophen-2-sulfonamide als Mittel gegen Glaukoma.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
ATE174911T1 (de) 1-dimethylcarbamoyl-1h-1,2,4-triazole- substituiert in stellungen 3 und 5
DE3767940D1 (de) Pyranderivate.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time